Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.55 USD | 0.00% |
|
-2.37% | +89.97% |
| Market Cap | 411M 546M 479M 447M 769M 52.26B 788M 5.31B 2.08B 25.86B 2.05B 2B 89.39B | P/E 2026 * |
-19.3x | P/E 2027 * | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 265M 352M 309M 288M 496M 33.69B 508M 3.42B 1.34B 16.67B 1.32B 1.29B 57.63B | EV / Sales 2026 * |
105x | EV / Sales 2027 * | 46.7x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 week | -2.37% | ||
| Current month | +5.19% | ||
| 1 month | +7.04% | ||
| 3 months | +62.45% | ||
| 6 months | +132.86% | ||
| Current year | +89.97% |
| 1 week | 10.55 |  | 12.19 |
| 1 month | 8.91 | | 12.19 |
| Current year | 4.19 | | 12.19 |
| 1 year | 4.19 | | 12.19 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/26 A | Sell | 865,112 | 0.6105% | |||
| 1/2/26 A | Free | Director | 90,000 | 0.0635% | ||
| 1/2/26 A | Free | Chief Technology Officer | 300,000 | 0.2117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.37% | +86.29% | +110.00% | 546M | |
| +0.64% | +6.68% | +0.73% | +14.49% | 48.95B | |
| +1.90% | +24.70% | +27.25% | +9.47% | 40.75B | |
| -1.60% | -1.15% | +388.84% | +603.70% | 38.46B | |
| -0.98% | +2.28% | +7.02% | +45.34% | 36.38B | |
| +1.47% | +5.82% | +5.76% | +43.52% | 28.45B | |
| -0.94% | +0.05% | - | - | 16.62B | |
| +2.44% | +10.76% | +30.59% | +129.56% | 16.33B | |
| -1.14% | +6.52% | -3.80% | -29.33% | 13.65B | |
| +0.29% | +4.11% | +4.18% | +10.00% | 13.56B | |
| Average | +0.21% | +4.97% | +60.76% | +104.08% | 25.37B | |
| Weighted average by Cap. | +0.26% | +6.90% | +72.02% | +122.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51M 3.34M 2.93M 2.74M 4.7M 320M 4.82M 32.48M 12.7M 158M 12.54M 12.26M 547M | 3.47M 4.61M 4.05M 3.78M 6.49M 441M 6.65M 44.82M 17.53M 218M 17.3M 16.93M 755M |
| Net income | -50.4M -66.96M -58.84M -54.92M -94.35M -6.41B -96.68M -651M -255M -3.17B -251M -246M -10.97B | -84.8M -113M -99M -92.41M -159M -10.79B -163M -1.1B -429M -5.34B -423M -414M -18.46B |
| Net Debt | -146M -194M -170M -159M -273M -18.57B -280M -1.89B -737M -9.19B -728M -712M -31.76B | -249M -331M -290M -271M -466M -31.66B -477M -3.21B -1.26B -15.67B -1.24B -1.21B -54.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | $11.55 | 0.00% | 595,348 |
| 28/07/26 | $11.55 | -4.31% | 1,190,811 |
| 27/07/26 | $12.07 | +9.53% | 666,332 |
| 24/07/26 | $11.02 | -3.76% | 341,873 |
| 23/07/26 | $11.45 | -3.21% | 480,128 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
